Hikma ups stake to take control of Tunisian pharma firm
This article was originally published in Scrip
Executive Summary
Jordan's Hikma Pharmaceuticals is to increase its stake in the Tunisian pharmaceutical manufacturing and marketing firm Industries Pharmaceutiques Ibn Al Baytar to 66%, enabling it to take control of the firm, consolidate its revenues and appoint a majority of the board.